Non-insulin Patch Pumps Market

Non-insulin patch pumps, also known as bolus injectors or large volume wearable injectors, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

Non-insulin Patch Pumps Market contains market size and forecasts of Non-insulin Patch Pumps in global, including the following market information:

• Global Non-insulin Patch Pumps Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Non-insulin Patch Pumps Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Non-insulin Patch Pumps companies in 2021 (%)

The global Non-insulin Patch Pumps market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

On-Body Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-insulin Patch Pumps include Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Non-insulin Patch Pumps manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-insulin Patch Pumps Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Non-insulin Patch Pumps Market Segment Percentages, by Type, 2021 (%)

• On-Body Injectors
• Off-Body Injectors

Global Non-insulin Patch Pumps Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Non-insulin Patch Pumps Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Home Care Settings
• Others

Global Non-insulin Patch Pumps Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Non-insulin Patch Pumps Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Non-insulin Patch Pumps revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Non-insulin Patch Pumps revenues share in global market, 2021 (%)
• Key companies Non-insulin Patch Pumps sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Non-insulin Patch Pumps sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ypsomed
• Amgen
• West Pharmaceuticals
• Unilife Corporation
• CeQur
• Sensile Medical
• BD Medical
• Enable Injections
• Sorrel Medical
• E3D Elcam Drug Delivery Devices